Molina Healthcare downgraded by Cantor Fitzgerald with a new price target
$MOH
Medical Specialities
Health Care
Cantor Fitzgerald downgraded Molina Healthcare from Overweight to Neutral and set a new price target of $210.00
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/25/2025 | $210.00 | Overweight → Neutral | Cantor Fitzgerald |
| 7/25/2025 | $180.00 | Buy → Hold | Truist |
| 7/10/2025 | $266.00 | Overweight → Equal-Weight | Morgan Stanley |
| 6/9/2025 | $364.00 | Overweight | Morgan Stanley |
| 4/22/2025 | $414.00 | Outperform | Bernstein |
| 4/15/2025 | $375.00 | Outperform → Neutral | Robert W. Baird |
| 3/5/2025 | $295.00 → $372.00 | Equal Weight → Overweight | Wells Fargo |
| 12/17/2024 | $378.00 → $350.00 | Neutral | Analyst |
Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below: Three months ended Six months ended June 30, June 30, 2025 2024 2025 2024 (In millions, except per-share results) Premium Revenue $10,868 $9,446 $21,496 $18,950 Total Revenue $11,427
Molina Healthcare, Inc. (NYSE:MOH) today announced preliminary financial results for the second quarter of 2025 and updated its full year 2025 adjusted earnings per share guidance. The Company's announcement of preliminary results was driven by recent market dynamics and off-cycle disclosures from others in the managed health care sector. The Company now expects its second quarter 2025 adjusted earnings to be approximately $5.50 per share(1), which is modestly below its prior expectations. This preliminary result reflects medical cost pressures in all three lines of business. The Company expects these medical cost pressures to continue into the second half of the year. As a result, the Co
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2025, after the market closes on Wednesday, July 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, July 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 4784585. A telephonic replay of the conference call will be available through Thursday, July 31, 2025, by dialing (877) 344-7529 and entering the confirmation number, 9484867. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relation
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below: Three months ended Six months ended June 30, June 30, 2025 2024 2025 2024 (In millions, except per-share results) Premium Revenue $10,868 $9,446 $21,496 $18,950 Total Revenue $11,427
Molina Healthcare, Inc. (NYSE:MOH) today announced preliminary financial results for the second quarter of 2025 and updated its full year 2025 adjusted earnings per share guidance. The Company's announcement of preliminary results was driven by recent market dynamics and off-cycle disclosures from others in the managed health care sector. The Company now expects its second quarter 2025 adjusted earnings to be approximately $5.50 per share(1), which is modestly below its prior expectations. This preliminary result reflects medical cost pressures in all three lines of business. The Company expects these medical cost pressures to continue into the second half of the year. As a result, the Co
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2025, after the market closes on Wednesday, July 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, July 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 4784585. A telephonic replay of the conference call will be available through Thursday, July 31, 2025, by dialing (877) 344-7529 and entering the confirmation number, 9484867. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relation
10-Q - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
Cantor Fitzgerald downgraded Molina Healthcare from Overweight to Neutral and set a new price target of $210.00
Truist downgraded Molina Healthcare from Buy to Hold and set a new price target of $180.00
Morgan Stanley downgraded Molina Healthcare from Overweight to Equal-Weight and set a new price target of $266.00
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)